Rodriguez-Martinez R, Ochoa S, Valle-Rios R, Jaimes-Ortega G, Hernandez-Castro R, Mancilla-Rojano J
Microorganisms. 2025; 13(2).
PMID: 40005742
PMC: 11858209.
DOI: 10.3390/microorganisms13020374.
Naramoto K, Kitahara G, Nazhat S, Yasuda M, Osawa T
J Vet Med Sci. 2024; 87(1):97-102.
PMID: 39631958
PMC: 11735222.
DOI: 10.1292/jvms.24-0177.
Han S, Chen Y, Lu Y, Jia M, Xu Y, Wang Y
BMC Endocr Disord. 2024; 24(1):214.
PMID: 39390505
PMC: 11468553.
DOI: 10.1186/s12902-024-01746-7.
Zhao J, Fang Z
Front Microbiol. 2024; 15:1420103.
PMID: 39372266
PMC: 11451479.
DOI: 10.3389/fmicb.2024.1420103.
Li J, Yang K, Yao F, Wei H
Front Pharmacol. 2024; 15:1469223.
PMID: 39359252
PMC: 11445020.
DOI: 10.3389/fphar.2024.1469223.
Plasma TNF-α Elevation in Biologic Naive Rheumatoid Arthritis Patients Belonging to a Population with New Mutations in TLR4 and CYP51A1 genes without Association with Disease-Related Antibodies Levels.
Mosavi E, Bandehpour M, Mostafazadeh A, Yousefghahari B, Majidi F, Zali H
Int J Mol Cell Med. 2024; 13(2):171-185.
PMID: 39184823
PMC: 11344565.
DOI: 10.22088/IJMCM.BUMS.13.2.171.
Targeting Tumor-Associated Macrophages with the Immune-Activating Nanomedicine for Achieving Strong Antitumor Activity with Rapid Clearance from the Body.
Ota Y, Inagaki R, Takanashi Y, Uemachi H, Matsuda K, Matsuoka M
ACS Nano. 2024; 18(34):23757-23772.
PMID: 39141816
PMC: 11363121.
DOI: 10.1021/acsnano.4c08811.
Revisiting the evolution of bow-tie architecture in signaling networks.
Itoh T, Kondo Y, Aoki K, Saito N
NPJ Syst Biol Appl. 2024; 10(1):70.
PMID: 38951549
PMC: 11217396.
DOI: 10.1038/s41540-024-00396-8.
The Recombinant Profilin from Free-Living Amoebae Induced Allergic Immune Responses via TLR2.
Park M, Park H, Yu H
J Inflamm Res. 2024; 17:2915-2925.
PMID: 38764493
PMC: 11100517.
DOI: 10.2147/JIR.S450866.
Maintenance of homeostasis by TLR4 ligands.
Oda M, Yamamoto H, Kawakami T
Front Immunol. 2024; 15:1286270.
PMID: 38715610
PMC: 11074394.
DOI: 10.3389/fimmu.2024.1286270.
The Effect of Heparin and Other Exogenous Glycosaminoglycans (GAGs) in Reducing IL-1β-Induced Pro-Inflammatory Cytokine IL-8 and IL-6 mRNA Expression and the Potential Role for Reducing Inflammation.
Jafri M, Li L, Liang B, Luo M
Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543157
PMC: 10976005.
DOI: 10.3390/ph17030371.
Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination.
Heine A, Lemmermann N, Flores C, Becker-Gotot J, Garbi N, Brossart P
Front Immunol. 2024; 15:1338499.
PMID: 38348028
PMC: 10860197.
DOI: 10.3389/fimmu.2024.1338499.
Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC.
Xia Y, Wang Y, Xiong Q, He J, Wang H, Islam M
Hepatology. 2024; 81(3):947-961.
PMID: 38266270
PMC: 11881075.
DOI: 10.1097/HEP.0000000000000762.
Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus.
Al-Busaidi A, Alabri O, Alomairi J, ElSharaawy A, Al Lawati A, Al Lawati H
Curr Diabetes Rev. 2024; 21(1):e170124225723.
PMID: 38243954
DOI: 10.2174/0115733998281910231231051814.
Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders.
Thomas S, Pak J, Doss-Gollin S, Ryff K, Beijnen E, Pedersen G
J Mol Biol. 2024; 436(4):168446.
PMID: 38242283
PMC: 10922990.
DOI: 10.1016/j.jmb.2024.168446.
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer's disease.
Qi X, Chen P, Wang Y, Zhou Z, Liu X, Fang H
Transl Neurodegener. 2024; 13(1):3.
PMID: 38191451
PMC: 10773087.
DOI: 10.1186/s40035-023-00394-6.
Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy.
Hoden B, Nagai Y, Schuettpelz L, Zhang D
Front Immunol. 2023; 14:1331317.
PMID: 38022608
PMC: 10679677.
DOI: 10.3389/fimmu.2023.1331317.
Extracellular Vesicles Induce Proinflammatory Immune Responses in BV-2 Microglial Cells.
Le H, Kang J, Vo T, Yoo W, Na B
Int J Mol Sci. 2023; 24(17).
PMID: 37686429
PMC: 10487526.
DOI: 10.3390/ijms241713623.
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases.
Ren W, Zhao L, Sun Y, Wang X, Shi X
Mol Med. 2023; 29(1):117.
PMID: 37667233
PMC: 10478470.
DOI: 10.1186/s10020-023-00717-3.
The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer.
Oseni S, Naar C, Pavlovic M, Asghar W, Hartmann J, Fields G
Cancers (Basel). 2023; 15(12).
PMID: 37370720
PMC: 10296711.
DOI: 10.3390/cancers15123110.